Montair
Montelukast tablets for asthma and allergic rhinitis. It blocks leukotrienes, the chemicals that set off airway swelling.
- Category
- Allergy Relief
- Active ingredient
- Montelukast
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg
Prescription and consultation requirements for Montair vary by destination and are determined by the fulfilment partner.
Montair details
- Alternative names
- montelukast
- Therapeutic class
- Leukotriene Receptor Antagonist
- Pharmacological class
- Antiasthmatic/Antiallergic
- Contraindications
- severe hypersensitivity to montelukast
- Minor side effects
- headache; nausea; cough
- Moderate side effects
- sinusitis; abdominal pain; fatigue
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 1–2 hours
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Phenobarbital; Rifampin
- Age restrictions
- Approved for paediatric and adult populations.
Serious side effects
neuropsychiatric events, requires immediate medical attention; systemic eosinophilia, requires immediate medical attention
Patient summary
Montelukast tablets for asthma and allergic rhinitis. It blocks leukotrienes, the chemicals that set off airway swelling.
Mechanism of action
Selectively blocks cysteinyl leukotriene receptors, resolving local airway hyperreactivity and mucosal oedema.
Pregnancy and breastfeeding
Pregnancy: Suitability during pregnancy depends on the specific medicine and individual circumstances. Confirm with a qualified clinician or pharmacist before use. Breastfeeding: Confirm breastfeeding suitability with a qualified clinician or pharmacist before use.